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Abstract
Background: A previous study (Goh G.K.-M., Dunker A.K., Uversky V.N. (2008) Protein intrinsic
disorder toolbox for comparative analysis of viral proteins. BMC Genomics. 9 (Suppl. 2), S4) revealed
that HIV matrix protein p17 possesses especially high levels of predicted intrinsic disorder (PID).
In this study, we analyzed the PID patterns in matrix proteins of viruses related and unrelated to
HIV-1.
Results: Both SIVmac and HIV-1 p17 proteins were predicted by PONDR VLXT to be highly
disordered with subtle differences containing 50% and 60% disordered residues, respectively.
SIVmac is very closely related to HIV-2. A specific region that is predicted to be disordered in HIV-
1 is missing in SIVmac. The distributions of PID patterns seem to differ in SIVmac and HIV-1 p17
proteins. A high level of PID for the matrix does not seem to be mandatory for retroviruses, since
Equine Infectious Anemia Virus (EIAV), an HIV cousin, has been predicted to have low PID level for
the matrix; i.e. its matrix protein p15 contains only 21% PID residues. Surprisingly, the PID
percentage and the pattern of predicted disorder distribution for p15 resemble those of the
influenza matrix protein M1 (25%).
Conclusion: Our data might have important implications in the search for HIV vaccines since
disorder in the matrix protein might provide a mechanism for immune evasion.
Background
The viral matrix protein underlies the envelope of a virion,
representing essentially a link between the envelope and
the nucleocapsid [1,2]. The functions of matrix proteins
are usually multifaceted, and not completely understood
[3-5]. They are however known to be involved in the viral
assembly and stabilization of the lipid envelope [6].
Matrix proteins of different viral types are often structur-
ally, functionally, and evolutionarily related [4]. For
instance, the influenza M1 and HIV p17 proteins are
known to be related and both have similar RNA and
membrane binding domains [4].
Lentivirinae is among the genii of viruses that possess a
matrix layer [7,8]. Viruses that belong to this genus
include Human Immunodeficiency Virus (HIV), Simian
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Immunodeficiency Virus (SIV), and Equine Infectious
Anemia Virus (EIAV). The viruses in this family have dif-
ferent characteristics [7,9,10]. This is especially so with
respect to the onset of diseases such as AIDS, the viral
loads and the success or failure in finding vaccines.
There are three known HIV viruses in the world today,
HIV-0, HIV-1, and HIV-2 [8,10,11]. The latter two are of
the most interest to our study. The HIV-1 is the predomi-
nant virus spreading around the globe. HIV-2, by contrast,
is predominantly spread in certain parts of Africa, being
found in about 10% of HIV cases in West Africa, and has
recently been found to be spreading in some parts of India
[8,11]. While the onset of AIDS usually occurs within an
average of 6 years of virtually all HIV-1 infections, those
infected with HIV-2 are allowed a much longer time
before the AIDS symptoms appear, if at all [8,11,12]. As
for SIV, a few strains such as SIVcpz are more closely related
to HIV-1, whereas most of the others, especially SIVsm,
and SIVmac, are closer to HIV-2 [10]. It should be noted
that SIV does not usually cause AIDS among African non-
human primates [13]. It does however cause AIDS among
Asia monkeys [14].
Similar to HIV and SIV, EIAV is another retrovirus [8,9],
which, however, spreads by insects, and the host targets
are non-cd4 white blood cells such as macrophages and
monocytes [8,15]. The disease caused by EIAV is not usu-
ally as fatal to its host as that of HIV and ~90% of infected
equine recovers from an initial onset of symptoms [8].
While the search for vaccines for HIV continues to be dif-
ficult and elusive, effective vaccine for EIAV had been
found 20 years ago in China [10,15,16]. A major difficulty
facing the search for HIV vaccines is a puzzling problem of
the inability of HIV protein-binding antibodies in elicit-
ing effective broad immune response [17]. While the rea-
son for this remains largely unknown [18], a finding of
high levels of intrinsically disordered proteins at the sur-
face, envelope or perhaps, matrix could provide a mecha-
nism by which the HIV virus evades the immune
response.
Therefore, these data clearly show that related viruses
might affect their hosts differently, possessing variable vir-
ulence and different modes of interaction with their host's
immune systems. A question then arises is whether some
of the mentioned variability in the behavior can be
reflected in some peculiar features of the corresponding
viral proteins. This paper examines matrix proteins of sev-
eral related viruses using computational tools such as
intrinsic disorder predictors to search for the crucial differ-
ences in the levels and distributions of intrinsic disorder
in the matrix proteins.
The concept of protein intrinsic disorder is used in this
paper to investigate characteristics pertaining to the vari-
ous viral matrix proteins. Intrinsically disordered proteins
have been described by other names such as "intrinsically
unstructured" [19,20], "natively unfolded" [21,22], and
"natively disordered" [23] among others. Historically, the
investigation of intrinsic disorder began with finding and
characterizing several proteins-exceptions from the para-
digm stating that unique rigid protein structure is an una-
voidable prerequisite for the specific protein function.
Although such counterexamples were periodically
observed, it was not till the end of the last century when
researchers started to pay significant attention to this phe-
nomenon [24]. As a result, the last decade witnessed the
real rise of unfoldomics, a new field of protein science
dealing with the various aspects of IDPs. It is recognized
now that many crucial biological functions are performed
by proteins which lack ordered tertiary and/or secondary
structure; i.e., by IDPs [19-21,23-31]. The fact that amino
acid sequences/compositions of IDPs and ordered pro-
teins are rather different was utilized to develop numer-
ous disorder predictors, which became instrumental in
the pursuit of a greater understanding of intrinsic disor-
der. Access to important information on many of these
predictors is provided via the DisProt database [32]. In
this paper, we utilized two members of the PONDR® fam-
ily of disorder predictors, VLXT and VL3 [33-38], to exam-
ine the matrix proteins of the various viruses especially
those related to HIV. PONDR® VL3 was chosen because of
its high accuracy in the prediction of long disordered
regions [36], whereas PONDR® VLXT was shown to be
extremely sensitive for finding function-related disor-
dered regions [35,39,40]. Uniqueness of this study is in
the fact that we applied disorder predictors to proteins
with known 3D-structure. This approach revealed some
peculiar patterns of PID that can be used to better under-
stand behavior of the HIV matrix proteins.
Table 1: A summary of matrix proteins and their percentages of 
disordered residues in a chain.
Protein Virus Accession % Predicted Disorder
M1 Influenza A 1ea3 25 (0)
Matrix (p17) SIVmac 1ed1 52 (40)
Matrix (p17) HIV-1 1hiw 61 (39)
Matrix(p15) EIAV 1hek 21 (12)
Capsid HIV-1 1afv 48 (0)
Capsid EIAV 1eia 30 (12)
All of the samples analyzed were structurally characterized using X-
ray crystallography. Percentage of predicted disorder corresponds to 
values produced by the PONDR® VLXT (VL3) analysesVirology Journal 2008, 5:126 http://www.virologyj.com/content/5/1/126
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Results
Quantifying Disorder by Calculating the Percentage of 
Predicted Disordered Residues
Table 1 represents the estimations of the percentage of
predicted disordered residues in the analyzed matrix and
capsid proteins. Even though influenza virus is quite unre-
lated to lentiviruses, its M1 matrix protein is placed here
for comparison. It is important to remember also that the
M1 protein is believed to be evolutionarily and structur-
ally related to the p17 matrix protein of HIV. Table 1
shows that the amount of intrinsic disorder varies from 20
to 61%, and from 0 to 40%, being evaluated by PONDR®
VLXT and VL3 respectively. Data for the four matrix pro-
teins with known 3-D structures are further illustrated by
Figure 1 showing the results of the PONDR® VLXT analysis
as bar chart. High level of predicted intrinsic disorder in
SIV and HIV-1 matrix proteins is clearly seen. In our ear-
lier paper [41], the following classification of proteins
characterized by X-ray crystallography but possessing var-
ious levels of predicted disorder was introduced: proteins
with percentage of residues predicted to be disordered by
PONDR® VLXT between 20–29% were considered moder-
ately disordered; those in the range of 30–39% were con-
sidered as quite disordered by prediction; whereas,
proteins that were disordered 40% and above were con-
sidered as very disordered by prediction. Therefore, the
influenza M1 protein and EIAV p15 should be considered
as moderately disordered by prediction. By the same rule,
the SIVmac and HIV-1 p17 matrix proteins have to be con-
sidered as highly disordered by prediction.
PONDR/B-Factor Plots and Contact Points
While Figure 1 and Table 1 represent the predicted disor-
der of whole polypeptide chains, the PONDR® VLXT plots
in Figure 2 represent per-residue distributions of disorder
scores. They can be used to measure and compare factors
that are not easily quantifiable. For example, Figure 2
allows us to correlate the protein-protein contact sites
(when such data are available) with the disorder score
profiles. It also compares the normalized B-factor values
[42] with the PONDR® VLXT plots.
Analysis of Figure 2 shows that contact sites (shown by
thick horizontal gray lines) always correlate either with
high B-factors or with high PONDR® VLXT scores suggest-
ing that highly flexible regions of matrix proteins are
responsible for protein-protein interactions. For example,
contacts between the subunits of HIV-1 p17 are located
near or within regions predicted to be disordered, whereas
contact sites of the EIAV p15 are mostly located in regions
with high B-factor. These observations are in a good agree-
ment with earlier studies which established the usefulness
of intrinsic disorder for protein-protein interaction [19-
21,23,25,29-31,35,39,40,43-46].
3-D Structures with Predicted Disorder
Figure 3 provides 3-D representations of the matrix pro-
teins from various viruses. The areas in magenta are the
protein regions predicted to be disordered by PONDR®
VL3 (and probably PONDR® VLXT also), whereas the
regions marked in red are those predicted to be disordered
by PONDR® VLXT. Different colors such as yellow and
green are used to denote different subunit regions. This
presentation of structured proteins allows visualization of
regions with the intrinsic propensity for being highly flex-
ible.
Discussion
HIV-1 Versus HIV-2 and SIVmac: Missing Regions Predicted 
to be Disordered
SIVmac is Very Similar to HIV-2
The HIV-2 and HIV-1 viruses, while related, differ in sub-
stantial ways in term of immune response, infection, and
the onset of AIDS [8,11,12]. SIVmac is a subtype of SIV,
which was first found in macaques and is known to be
very closely related to HIV-2 [10]. While development of
AIDS symptoms are seen in virtually all HIV-1 infected
patients, AIDS symptoms of HIV-2 infection appears only
in a small percentage of patients. We believe that a com-
parative analysis of PID in related viral proteins could
shed some light on the reasons behind these behaviors.
PID Rates of Matrix Proteins Correlate with the Difficulties in Finding 
Vaccines
A brief glance at Table 1 and Figure 1 shows that the PID
rates of SIVmac and HIV-1 are quite similar, even though
the percentage of PID in SIVmac p17 (50% by PONDR®
VLXT) is smaller than that in HIV-1 p17 (61%). The simi-
larity in the level of PID is likely indicative of the ability of
both viruses to evade the immune system. Further support
A bar chart comparing matrix proteins across virus types Figure 1
A bar chart comparing matrix proteins across virus 
types.Virology Journal 2008, 5:126 http://www.virologyj.com/content/5/1/126
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PONDR/B-factor plots of matrix proteins of various viruses A) the influenza A M1 protein B) the SIVmac P17 protein Figure 2
PONDR/B-factor plots of matrix proteins of various viruses A) the influenza A M1 protein B) the SIVmac P17 
protein. C) HIV-1 p17 Matrix protein D) The EIAV p15 Matrix protein. Protein-protein contacts between chains are anno-
tated by thick gray horizontal spots. The normalized B-factor values are seen in the light gray curves. PONDR-VLXT scores 
are seen in the black curve in each plot.Virology Journal 2008, 5:126 http://www.virologyj.com/content/5/1/126
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The three dimensional structures of the matrix proteins of the various viruses with predicted disorder annotation by red and  magenta colors Figure 3
The three dimensional structures of the matrix proteins of the various viruses with predicted disorder annota-
tion by red and magenta colors. A) The influenza m1 protein B) SIVmac p17 Protein C) HIV-1 p17 protein shown as a 
monomer D) The EIAV p15 E) The HIV-1 p17 shown as a multimer. The regions in magenta are regions predicted to be disor-
dered by VL3 (and probably also by VLXT). By contrast, the regions in red are areas predicted to be disordered by VLXT.


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Page 6 of 10
(page number not for citation purposes)
for this hypothesis can be retrieved by analyzing the level
of predicted disorder in the influenza M1 protein and in
the EIAV p15 protein. Matrix proteins of both of the
viruses have low percentage disorder rates, 25% in M1 and
21% in p15. Interestingly, effective vaccines were devel-
oped for both of these viruses, even though the mutation
rates of the influenza virus is extremely high causing well-
known difficulties in the development of new vaccines.
Apparently, the PID rate is a good predictor of the ease of
vaccine development of a virus. This should not be sur-
prising as our earlier study [41] suggested that the viral
matrix likely helps viruses to evade detection by the
immune system due to its highly dynamic nature and con-
stant motions. This dynamic behavior is correlated with
the high propensity of matrix proteins for intrinsic disor-
der. Furthermore, it has been hypothesized that the role
may be intertwined with the glycoprotein on the surface
acting as a broom in a sweeping motion provided by the
matrix [41]. This highly dynamic nature of the viral sur-
face may explain the difficulties in the development of
vaccine for HIV.
Qualitative Differences in Predicted Disorder and Protein-Protein 
Interactions
Even though the rates of predicted disorder in the SIVmac
and HIV-1 p17 proteins seem to be similarly high, the
PONDR® VLXT plots revealed subtle differences in the dis-
order distribution within the protein sequences. Figures
2B and 2C show that a long region predicted to be disor-
dered by HIV-1 p17 (53–76 fragment) is missing in SIVmac
p17. Figures 3B, 3C, and 3E illustrate that this fragment in
HIV-1 p17 forms an α-helix and is involved in protein-
protein interactions between the subunits. In fact, resi-
dues 70–73 from one subunit contact with residues 71,
60, 40, and 46 from another subunit. Analysis of Figure
2C revealed that all these inter-subunit contact sites are
located within the PID regions. Therefore, intrinsic disor-
der plays a crucial role in the inter-subunit interactions,
which can be classified as disorder-disorder type of con-
tact. The lack of a predicted to be disordered segment in
HIV-2 and SIVmac which seems to be crucial for inter-sub-
unit contacts suggests that disorder-disorder protein-pro-
tein interactions are replaced by the order-disorder or
order-order interactions.
Predicted Disorder Patterns Correlate with High B-Factors
Figure 2 shows that, in general, there is a rather good cor-
relation between the predicted disorder patterns and the
normalized B-factor curves. For example, the 79–95 frag-
ment of the HIV-1 matrix protein is both predicted to be
disordered and is characterized by the high normalized B-
factor values (Figure 2C, 1hiw.pdb). In several occasions,
there are noticeable lags between the PONDR® VLXT and
B-factor curves, as it is seen, e.g. in Figure 2A (M1 matrix
proteins of the influenza A virus, 1ea3.pdb), where large
B-factor peaks are seen in the 70–90 region, whereas the
corresponding PID fragment is located in the 90–105
region.
HIV versus EIAV: Higher Predicted Disorder in HIV
Matrix of EIAV Is Relatively Ordered
Matrix protein of EIAV was predicted to be less disordered
than that of HIV (see Table 1 and Figure 1). However, even
in this case less abundant PID regions could be crucial for
the inter-subunit interactions. In fact, analysis of the crys-
tal structure of the p15 protein revealed that residues 46
and 78 of the chain A are involved in interaction with the
residues 114 and 105 of the chain B. All these interaction
sites are shown as thick gray lines in Figure 2D, which
clearly indicates that the interactions between the 15 sub-
units are less rigorous than that of HIV-1 p17 subunits
and can be ascribed to the order-disorder contact type.
Since EIAV is from the same genus as HIV, that is, lentivi-
ranae [9,15], these data suggest that the high PID levels
are not a common characteristics of the retroviradae fam-
ily, or even the lentiviranae genus. Apparently, the high
level of intrinsic disorder in the matrix proteins is a char-
acteristic feature of HIV-1 and its closest relatives, SIV and
HIV-2. These differences in the abundance of disorder
seem to be largely constrained to the matrix proteins as
the capsids of both HIV-1 and EIAV viruses are quite dis-
ordered by prediction (48% and 30% by PONDR® VLXT,
see Table 1).
Predicted Disorder Patterns of EIAV Are Closer to Those of Influenza 
than of disorder patterns of HIV/SIV
Analysis of Figure 2 reveals that the pattern of the pre-
dicted disorder in EIAV matrix protein is closer to that of
the influenza virus than to the disorder profiles of the
EIAV's cousins HIV and SIV. Furthermore, EIAV and Influ-
enza A matrix proteins are similar in their relatively low
percentages of the predicted disorder (21% in EIAV and
25% in Influenza). The other similarity has to do with the
interaction mode between the matrix protein subunits. In
fact, contact sites of both Influenza A and EIAV matrix
proteins can be classified as disorder-order contacts. In the
case of HIV-1, most of the contact sites between the subu-
nits are predicted disorder-disorder interactions. Compar-
ison of the disorder and B-factor profiles of the HIV-1 and
SIVmac p17 proteins allows extrapolation to be made of
the potential modes of inter-subunit interactions in SIVmac
p17. In fact, if potential interaction sites are distributed
similarly within the amino acid sequences of HIV-1 and
SIVmac p17 proteins, then at least some of the SIVmac p17
inter-subunit interactions site can be assigned as disorder-
disorder interactions (e.g. if the residue 111 of one SIVmac
p17 subunit is in contact with the residue 97 from another
subunit, then disorder-disorder contact takes place as
both of these residues are predicted to be disordered, as
seen in Figure 2B).Virology Journal 2008, 5:126 http://www.virologyj.com/content/5/1/126
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High Intrinsic Disorder and Immune Response
Potential Implications of More Disordered Matrix Proteins: Immune 
Evasion
The question then arose: What are the potential implica-
tions of more rigid or more disordered matrix proteins? It
is likely that more rigid p17 proteins may be less effective
in evading immune response. This may be a reason why
HIV-2 and SIVmac are less pathogenic than HIV-1. It is gen-
erally assumed that HIV-2 is less pathogenic than HIV-1
because of the fact that HIV-2 has lesser affinity for CD4
than HIV-1. On the other hand, our data show that there
are subtle but important differences between HIV-1 and
SIVmac (HIV-2) in their patterns of predicted disorder dis-
tribution, which also might contribute to the virus's abil-
ity to evade the host immune system.
Implication to the Search for HIV Vaccines
Our findings might also have some implications to the
search for HIV vaccines. One possibility is related to the
use animal models and SIVmac as in the search for HIV vac-
cination and drugs. SIVmac and SIVstm were the first sub-
types found in laboratory macaques [13]. Asian primates
such as macaques, unlike their African cousins, developed
AIDS on the average of 10 years after infection [8]. For this
reason, the use of SIV on Asian monkeys has become the
standard animal model [47]. However, the extrapolation
of data from animal models to HIV in human remains a
challenge. Our results suggest that some of these chal-
lenges could be explained by the differences in disorder
prediction between HIV-1 and SIV (or HIV-2). It is also
important to remember that although the high levels of
mutation caused difficulties in the development of vac-
cines against new strains of the influenza, there are effec-
tive vaccines against specific strains of the virus. Similarly,
there are also effective vaccines available of EIAV. Note,
matrix proteins of both influenza virus and EIAV are
shown in our study to contain less amount of intrinsic dis-
order.
Joint Role of Glycoproteins and Matrix Disorder
It is established that the HIV envelope glycoprotein gp120
is one of the most glycosylated proteins in nature [48].
Oligosaccharide moieties of viral glycoproteins often hide
them from recognition by immune agents such as anti-
bodies [16]. We propose that abnormally disordered
matrix proteins might help the surface glycoprotein in
eluding immune responses. In other words, intrinsic dis-
order (read high dynamics) underneath the envelope
would work in a tandem with envelope glycoproteins to
help viruses in the avoiding of the induction of immune
response. The questions then arose: How and why would
surface glycoprotein and matrix disorder work in cooper-
ation? A likely scenario is shown in Figure 4. Here, the oli-
gosaccharide moieties of the glycoproteins act as an
entropic brush that protects viral surface proteins such as
gp120 and gp41 from contacts with immune agents such
as antibodies. The matrix protein could then provide the
additional motion to the sweep. An advantage of motions
that resemble a broom in a sweep is that it enables some
regulatory roles via the matrix protein. Earlier it has been
already observed that the envelope proteins are very sen-
sitive to the behavior of the matrix proteins [3].
Conclusion
Matrix Disorder of Retroviruses Varies with Nature of the 
Virus
A peculiar finding of this paper is the pattern of predicted
disorder of EIAV p15 matching more closely the disorder
profile of the influenza M1 protein than those of the
matrix proteins of its closer relatives, namely the HIV-1
and SIVmac p17 proteins. This feature may be attributed to
the ways the viruses are evolved and are transmitted to
their hosts. It should be reminded that EIAV is transmitted
between horses via insect vectors. In other words, the virus
experience dramatic change in the environment during
the transmission. It is likely that this mode of transmis-
sion has evolutionary requirements similar to those of the
influenza virus, which is transmitted via respiratory tract
and mucus. HIV and SIV, on the other hand, spread by
blood contact or sexual activities. Since it there lesser
chance for the exposure to the outside environment in the
transmission mode, there is hence lesser evolutionary
pressure for the matrix proteins to be ordered. This high-
lights a role for the matrix protein in many viruses. In
many instances, the matrix acts as an encasement for the
virion, thereby protecting the virion from damage espe-
cially in adverse environments. We have also seen that dis-
order at the matrix is not an absolute characteristic of
retroviruses.
Implication for the Immune System Invisibility Puzzle of 
HIV
A single nagging puzzle in the search for vaccines against
HIV is the unknown mechanisms helping the virus to
evade immune response. Our study suggests that this abil-
ity might arise from the abnormal levels of intrinsic disor-
der at the viral matrix. This hypothesis is supported by the
fact that the matrix proteins of other viruses, where vac-
cines have been more easily found, were predicted to be
more ordered. Therefore, there are several ways how dis-
order predictions can be utilized in the future strategies of
the vaccine development. Particularly, one of the new
directions in the anti-HIV drug development could be a
search for the therapeutic agents able to stabilize the HIV
matrix protein.
Another puzzle of HIV viruses is the inability of virologists
to account for the waves of the HIV strains seen, even after
taking into account the fact that the mutation rate of HIV-
1 is 25-times that of influenza. Yet another HIV puzzle isVirology Journal 2008, 5:126 http://www.virologyj.com/content/5/1/126
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the greater pathogenicity of HIV-1 as compared to HIV-2.
It has been generally understood that this is due to the fact
that the HIV-1 affinity for CD4 is 28 times greater than
that of HIV-2 [49]. Our data suggest that it is not just the
affinity for CD4 that give rise to a greater pathogenesis or
viral load in HIV-1. Perhaps, it is also the differences in the
abilities of the viruses in evading the immune system via
disorder at the matrix. This also explains a related obser-
vation among epidemiologists that the more easily that
HIV-1 spreads sexually the more virulent it becomes [8],
since the ease of transmission via blood or sexual inter-
course lessens the requirements for a rigid encasement of
the virion, which is used in other viruses to prevent virion
damage due to harsh environmental factors.
Potential implications for the Immune Evasion of Cancer 
Cells and Oncolysis
While this paper has been largely focused on the study of
immune evasion as applied to HIV and HIV-related
viruses, it may provide a model for immune evasion by
other entities, such as cancer cells. There are either very
few or no studies done in this area. Perhaps, our results
could invigorate interest in this area, given the models and
approach used. Furthermore, the results of this paper
likely have novel strategic implications for experimental
studies on the use of viruses as oncolytic agents, which
have often been observed to be rendered ineffective by the
immune system. In fact, one of the greatest problems in
using the oncolytic viruses is that they are detected by the
immune system very quickly so they are only useful for
localized treatment of tumors [50]. Our data suggest that
this does not have to be always the case and new oncolytic
viruses with disordered matrix should be considered.
Methods
PDB Accessions
A full description of implementation techniques can be
found in a previous paper [41]. The search for important
proteins suitable for analysis was done using the Entrez
website [51]. Proteins from retroviruses and relatives of
HIV were carefully reviewed. The accession codes were
grouped into two classes containing proteins whose struc-
Schematic diagram: glycoconjugate acts as a broom with sweeping motion arising from matrix Figure 4
Schematic diagram: glycoconjugate acts as a broom with sweeping motion arising from matrix. The striped 
arrows depict the motions of oligosaccharides arising from the bobbing of the lipid bilayer. The motions of the membrane is 
also dependent on the matrix for stability or lack of it. The motions of the oligosaccharide may allow and prevent the binding 
of CD4 and antibodies respectively.Virology Journal 2008, 5:126 http://www.virologyj.com/content/5/1/126
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tures were elucidated using NMR or X-ray diffraction. It
should be also noted that suitable data were unavailable
for HIV-2. SIVmac was used in lieu of HIV-2 since the two
are genetically close and the X-ray diffraction data for
EIAV matrix and capsid proteins were readily available.
Query Language
Given the appropriate accessions selected, JAVA programs
were used to automatically place the necessary informa-
tion into the MYSQL database. The data were often
checked using the SQL (Sequel Query Language) [52].
PONDR® VLXT and PONDR® VL3
PONDR® (Predictor Of Natural Disordered Regions) is a
set of neural network predictors of disordered regions on
the basis of local amino acid composition, flexibility,
hydropathy, coordination number and other factors.
These predictors classify each residue within a sequence as
either ordered or disordered. PONDR® VL-XT integrates
three feed forward neural networks: the Variously charac-
terized Long, version 1 (VL1) predictor from Romero et al.
2001 [33], which predicts non-terminal residues, and the
X-ray characterized N- and C-terminal predictors (XT)
from [53], which predicts terminal residues. Output for
the VL1 predictor starts and ends 11 amino acids from the
termini. The XT predictors output provides predictions up
to 14 amino acids from their respective ends. A simple
average is taken for the overlapping predictions; and a
sliding window of 9 amino acids is used to smooth the
prediction values along the length of the sequence. Uns-
moothed prediction values from the XT predictors are
used for the first and last 4 sequence positions.
PONDR® VL3 combines the predictions of 30 neural net-
works for the entire protein sequence and was trained
using disordered regions from more than 150 proteins
characterized by the methods mentioned above plus cir-
cular dichroism, limited proteolysis and other physical
approaches [36].
Protein-Protein Contacts and PONDR Plots
In order to detect the locations of protein-protein contacts
between the different chains of proteins (i.e., when atoms
of neighboring chains are within 3.0 Å from each other),
a JAVA program was written to check the interchain atom-
atom distance. The program generated graphs with
PONDR plots with locations of the protein-protein con-
tacts.
Three Dimensional Analysis with Disorder Prediction
The JAVA programming language was used to generate
codes readable by the molecular 3D software, Jmol [54].
In resulting structures, regions of predicted disorder were
annotated by red (VLXT) or magenta (VL3). Areas shaded
by magenta were also regions likely predicted to be disor-
dered by VLXT.
B-Factor
B-Factor values were imported directly from the PDB files
into the table access_seq [41] that was modified to accom-
modate for the B-factor values [42].
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GKMG proposed the idea of the study, carried out the
analyses and drafted the manuscript. AKD helped to
design experiments and participated in the manuscript
drafting. VNU coordinated the studies, participated in
their design and helped to draft the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
This work was supported in part by the grants R01 LM007688-01A1 and 
GM071714-01A2 from the National Institutes of Health. We gratefully 
acknowledge the support of the IUPUI Signature Centers Initiative.
References
1. Turner BG, Summers MF: Structural biology of HIV.  J Mol Biol
1999, 285:1-32.
2. Cannon PM, Matthews S, Clark N, Byles ED, Iourin O, Hockley DJ,
Kingsman SM, Kingsman AJ: Structure-function studies of the
human immunodeficiency virus type 1 matrix protein, p17.  J
Virol 1997, 71:3474-3483.
3. Dorfman T, Mammano F, Haseltine WA, Gottlinger HG: Role of the
matrix protein in the virion association of the human immu-
nodeficiency virus type 1 envelope glycoprotein.  J Virol 1994,
68:1689-1696.
4. Harris A, Sha B, Luo M: Structural similarities between influ-
enza virus matrix protein M1 and human immunodeficiency
virus matrix and capsid proteins: an evolutionary link
between negative-stranded RNA viruses and retroviruses.  J
Gen Virol 1999, 80(Pt 4):863-869.
5. Hearps AC, Jans DA: Regulating the functions of the HIV-1
matrix protein.  AIDS Res Hum Retroviruses 2007, 23:341-346.
6. Lyles DS, McKenzie M, Parce JW: Subunit interactions of vesicu-
lar stomatitis virus envelope glycoprotein stabilized by bind-
ing to viral matrix protein.  J Virol 1992, 66:349-358.
7. Clements JE, Zink MC: Molecular biology and pathogenesis of
animal lentivirus infections.  Clin Microbiol Rev 1996, 9:100-117.
8. Goudsmit J: Viral Sex: The Nature of AIDS.  Oxford University
Press, New York; 1997. 
9. Leroux C, Cadore JL, Montelaro RC: Equine Infectious Anemia
Virus (EIAV): what has HIV's country cousin got to tell us?
Vet Res 2004, 35:485-512.
10. Marx PA, Li Y, Lerche NW, Sutjipto S, Gettie A, Yee JA, Brotman BH,
Prince AM, Hanson A, Webster RG, et al.: Isolation of a simian
immunodeficiency virus related to human immunodefi-
ciency virus type 2 from a west African pet sooty mangabey.
J Virol 1991, 65:4480-4485.
11. Jurriaans S, van Gemen B, Weverling GJ, van Strijp D, Nara P,
Coutinho R, Koot M, Schuitemaker H, Goudsmit J: The natural his-
tory of HIV-1 infection: virus load and virus phenotype inde-
pendent determinants of clinical course?  Virology 1994,
204:223-233.
12. Morgan D, Mahe C, Mayanja B, Whitworth JA: Progression to
symptomatic disease in people infected with HIV-1 in rural
Uganda: prospective cohort study.  BMJ 2002, 324:193-196.
13. Chen Z, Telfer P, Reed P, Zhang L, Getti A, Ho DD, Marx PA: Isola-
tion and characterization of the first simian immunodefi-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Virology Journal 2008, 5:126 http://www.virologyj.com/content/5/1/126
Page 10 of 10
(page number not for citation purposes)
ciency virus from a feral sooty mangabey (Cercocebus atys)
in West Africa.  J Med Primatol 1995, 24:108-115.
14. Apetrei C, Lerche NW, Pandrea I, Gormus B, Silvestri G, Kaur A,
Robertson DL, Hardcastle J, Lackner AA, Marx PA: Kuru experi-
ments triggered the emergence of pathogenic SIVmac.  AIDS
2006, 20:317-321.
15. Beyrer C: Injecting drug users and HIV vaccine trials: What
does the science say?  AIDScience 2002, 2:1-6.
16. Burton DR, Stanfield RL, Wilson IA: Antibody vs. HIV in a clash
of evolutionary titans.  Proc Natl Acad Sci USA 2005,
102:14943-14948.
17. McMichael A, Mwau M, Hanke T: Design and tests of an HIV vac-
cine.  Br Med Bull 2002, 62:87-98.
18. Burton DR: Antibodies, viruses and vaccines.  Nat Rev Immunol
2002, 2:706-713.
19. Wright PE, Dyson HJ: Intrinsically unstructured proteins: re-
assessing the protein structure-function paradigm.  J Mol Biol
1999, 293:321-331.
20. Tompa P: Intrinsically unstructured proteins.  Trends Biochem Sci
2002, 27:527-533.
21. Uversky VN, Gillespie JR, Fink AL: Why are "natively unfolded"
proteins unstructured under physiologic conditions?  Proteins
2000, 41:415-427.
22. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr:
NACP, a protein implicated in Alzheimer's disease and
learning, is natively unfolded.  Biochemistry 1996,
35:13709-13715.
23. Daughdrill GW, Pielak GJ, Uversky VN, Cortese MS, Dunker AK:
Natively disordered proteins.  In Protein Folding Handbook Edited
by: Buchner J, Kiefhaber T. Wiley-VCH, Verlag GmbH & Co. KGaA,
Weinheim, Germany; 2005:271-353. 
24. Dunker AK, Oldfield CJ, Meng J, Romero P, Yang JY, Cheng JW, Vacic
V, Obradovic Z, Uversky VN: The unfoldomics decade: An
update on intrinsically disordered proteins.  BMC Genomics
2008, 9:S1.
25. Uversky VN, Oldfield CJ, Dunker AK: Showing your ID: intrinsic
disorder as an ID for recognition, regulation and cell signal-
ing.  J Mol Recognit 2005, 18:343-384.
26. Xie H, Vucetic S, Iakoucheva LM, Oldfield CJ, Dunker AK, Obradovic
Z, Uversky VN: Functional anthology of intrinsic disorder. 3.
Ligands, post-translational modifications, and diseases asso-
ciated with intrinsically disordered proteins.  J Proteome Res
2007, 6:1917-1932.
27. Vucetic S, Xie H, Iakoucheva LM, Oldfield CJ, Dunker AK, Obradovic
Z, Uversky VN: Functional anthology of intrinsic disorder. 2.
Cellular components, domains, technical terms, develop-
mental processes, and coding sequence diversities corre-
lated with long disordered regions.  J Proteome Res 2007,
6:1899-1916.
28. Xie H, Vucetic S, Iakoucheva LM, Oldfield CJ, Dunker AK, Uversky
VN, Obradovic Z: Functional anthology of intrinsic disorder. 1.
Biological processes and functions of proteins with long dis-
ordered regions.  J Proteome Res 2007, 6:1882-1898.
29. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradovic Z:
Intrinsic disorder and protein function.  Biochemistry 2002,
41:6573-6582.
30. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS,
Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, Ausio J, Nissen MS,
Reeves R, Kang C, Kissinger CR, Bailey RW, Griswold MD, Chiu W,
Garner EC, Obradovic Z: Intrinsically disordered protein.  J Mol
Graph Model 2001, 19:26-59.
31. Dyson HJ, Wright PE: Intrinsically unstructured proteins and
their functions.  Nat Rev Mol Cell Biol 2005, 6:197-208.
32. Sickmeier M, Hamilton JA, LeGall T, Vacic V, Cortese MS, Tantos A,
Szabo B, Tompa P, Chen J, Uversky VN, Obradovic Z, Dunker AK:
DisProt: the Database of Disordered Proteins.  Nucleic Acids
Res 2007, 35:D786-793.
33. Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, Dunker AK:
Sequence complexity of disordered protein.  Proteins 2001,
42:38-48.
34. Vucetic S, Brown CJ, Dunker AK, Obradovic Z: Flavors of protein
disorder.  Proteins 2003, 52:573-584.
35. Garner E, Romero P, Dunker AK, Brown C, Obradovic Z: Predict-
ing binding regions within disordered proteins.  Genome Inform
Ser Workshop Genome Inform 1999, 10:41-50.
36. Obradovic Z, Peng K, Vucetic S, Radivojac P, Brown CJ, Dunker AK:
Predicting intrinsic disorder from amino acid sequence.  Pro-
teins 2003, 53(Suppl 6):566-572.
37. Dunker AK, Garner E, Guilliot S, Romero P, Albrecht K, Hart J, Obra-
dovic Z, Kissinger C, Villafranca JE: Protein disorder and the evo-
lution of molecular recognition: theory, predictions and
observations.  Pac Symp Biocomput 1998:473-484.
38. Romero P, Obradovic Z, Kissinger CR, Villafranca JE, Garner E, Guil-
liot S, Dunker AK: Thousands of proteins likely to have long
disordered regions.  Pac Symp Biocomput 1998:437-448.
39. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN, Dunker
AK: Comparing and combining predictors of mostly disor-
dered proteins.  Biochemistry 2005, 44:1989-2000.
40. Cheng Y, Oldfield CJ, Meng J, Romero P, Uversky VN, Dunker AK:
Mining alpha-helix-forming molecular recognition features
with cross species sequence alignments.  Biochemistry 2007,
46:13468-13477.
41. Goh GK-M, Dunker AK, Uversky VN: Protein intrinsic disorder
toolbox for comparative analysis of viral proteins.  BMC
Genomics 2008, 9:S4.
42. Radivojac P, Obradovic Z, Smith DK, Zhu G, Vucetic S, Brown CJ,
Lawson JD, Dunker AK: Protein flexibility and intrinsic disor-
der.  Protein Sci 2004, 13:71-80.
43. Dunker AK, Cortese MS, Romero P, Iakoucheva LM, Uversky VN:
Flexible nets. The roles of intrinsic disorder in protein inter-
action networks.  FEBS J 2005, 272:5129-5148.
44. Uversky VN: What does it mean to be natively unfolded?  Eur J
Biochem 2002, 269:2-12.
45. Uversky VN: Natively unfolded proteins: a point where biol-
ogy waits for physics.  Protein Sci 2002, 11:739-756.
46. Uversky VN: Protein folding revisited. A polypeptide chain at
the folding-misfolding-nonfolding cross-roads: which way to
go?  Cell Mol Life Sci 2003, 60:1852-1871.
47. Hulskotte EG, Geretti AM, Osterhaus AD: Towards an HIV-1 vac-
cine: lessons from studies in macaque models.  Vaccine 1998,
16:904-915.
48. Vigerust DJ, Shepherd VL: Virus glycosylation: role in virulence
and immune interactions.  Trends Microbiol 2007, 15:211-218.
49. Chakravarty J, Mehta H, Parekh A, Attili SV, Agrawal NR, Singh SP,
Sundar S: Study on clinico-epidemiological profile of HIV
patients in eastern India.  J Assoc Physicians India 2006, 54:854-857.
50. Chernajovsky Y, Layward L, Lemoine N: Fighting cancer with onc-
olytic viruses.  BMJ 2006, 332:170-172.
51. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H,
Shindyalov IN, Bourne PE: The Protein Data Bank.  Nucleic Acids
Res 2000, 28:235-242.
52. Pratt PJ, Adamski JJ: Concepts of Database Management 4th edition.
Thomson Course Technology, Boston, MA; 2002. 
53. Li X, Romero P, Rani M, Dunker AK, Obradovic Z: Predicting pro-
tein disorder for N-, C-, and internal regions.  Genome Inform
Ser Workshop Genome Inform 1999, 10:30-40.
54. Herráez A: Biomolecules in the computer: Jmol to the rescue.
Biochemistry and Molecular Biology Education 2006, 34:255-261.